Jane Street’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Sell
92,475
-125,062
-57% -$3.06M ﹤0.01% 5289
2025
Q4
$5.83M Buy
217,537
+69,078
+47% +$1.78M ﹤0.01% 3005
2025
Q3
$3.96M Sell
148,459
-11,623
-7% -$300K ﹤0.01% 3771
2025
Q2
$3.68M Buy
160,082
+113,417
+243% +$2.81M ﹤0.01% 3438
2025
Q1
$1.35M Sell
46,665
-52,822
-53% -$1.69M ﹤0.01% 5020
2024
Q4
$3.69M Buy
99,487
+35,873
+56% +$1.64M ﹤0.01% 3102
2024
Q3
$3.09M Sell
63,614
-33,100
-34% -$1.45M ﹤0.01% 3673
2024
Q2
$3.87M Buy
96,714
+57,854
+149% +$2.4M ﹤0.01% 3373
2024
Q1
$1.71M Sell
38,860
-13,119
-25% -$678K ﹤0.01% 4414
2023
Q4
$3.21M Buy
51,979
+11,868
+30% +$623K ﹤0.01% 3534
2023
Q3
$1.84M Buy
40,111
+23,297
+139% +$1.27M ﹤0.01% 4189
2023
Q2
$966K Sell
16,814
-11,529
-41% -$511K ﹤0.01% 5246
2023
Q1
$1.06M Buy
28,343
+20,094
+244% +$659K ﹤0.01% 4884
2022
Q4
$231K Sell
8,249
-29,046
-78% -$843K ﹤0.01% 7445
2022
Q3
$1.05M Buy
37,295
+19,710
+112% +$644K ﹤0.01% 5331
2022
Q2
$612K Buy
17,585
+8,309
+90% +$297K ﹤0.01% 6375
2022
Q1
$333K Sell
9,276
-10,090
-52% -$286K ﹤0.01% 8235
2021
Q4
$451K Buy
+19,366
New +$396K ﹤0.01% 7454

Other funds holding AMPH

Jane Street's AMPH Position: Q1 2026 in Review

Jane Street reduced its Amphastar Pharmaceuticals (AMPH) stake by 57% in Q1 2026, selling an estimated $3.06M and leaving 92,475 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #5289.

Jane Street first reported a position in AMPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.83M in Q4 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Jane Street held 92,475 shares of Amphastar Pharmaceuticals worth $1.81M as of Q1 2026.
  • Jane Street sold 125,062 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $3.06M.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5289 holding.
  • Jane Street first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Jane Street's Amphastar Pharmaceuticals position peaked at $5.83M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.